Rupee Closes 21 Paise Stronger Against Weakening Dollar
The Indian rupee closed 21 paise stronger at 85.49 against the US dollar on Friday in comparison to its previous close of Rs 85.70 on Thursday. The currency's advance comes amid ongoing market uncertainty and geopolitical tensions.
The Indian rupee opened 20 paise stronger against the US dollar on Friday, trading at Rs 85.70.
"The Indian Rupee strengthened on Friday morning trade, bolstered by weak US data that boosted expectations of rate cuts by the Fed," said Sriram Iyer, Senior Research Analyst at Reliance Securities.
The rupee is facing pressure after a recent decline from the 86.70 zone. The price is hovering near the 20-day SMA, which is acting as dynamic support. "A break below this level may lead to further downside towards 85.00 and 84.75," said Ritesh Bhansali, director, Mecklai Financial Service Ltd.
Additionally, the US dollar index fell to its lowest since early 2022, as dovish signals from the Federal Reserve and the White House fueled expectations of rate cuts.
Fed Chair Powell suggested the easing cycle would have continued in absence of tariff-driven inflation, while reports indicate US President Donald Trump may nominate a more dovish Fed Chair as early as September or October The market now turns to today's PCE inflation data for confirmation, said Bhanshali.
Oil rose higher on Friday after a report by the US government has shown a sharp decline in the American crude stockpile. Investors are also awaiting the July 6 OPEX+ meeting. Oil is likely to post its biggest weekly decline in nearly two years with Brent down nearly 12% for the week.
While Brent crude and West Texas Intermediate crude oil rose 0.72% each.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.